Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
Zacks Investment Research on MSN12d
Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRMBruker Corporation BRKR recently launched the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). Representing a significant leap in benchtop XRM ...
As it happens, Bruker issued 9.5% more new shares over the last year. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much ...
Similar improvements are observed in immunopeptidomics. Bruker expects to launch the new AIP on the timsTOF Ultra 2 system at ASMS 2025 with timsTOF Ultra 2 field upgradability. B. DeutEx ...
Peptides were dissolved in mass spectrometry loading buffer and analyzed via liquid chromatography–tandem mass spectrometry using the EASY‐nLC 1200 system (Thermo Fisher Scientific) coupled with the ...
Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio 43210, United States Native MS Guided Structural Biology Center, The Ohio State University, Columbus, Ohio 43210, ...
2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...
Bruker (BRKR) reported $979.6 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 14.6%. EPS of $0.76 for the same period compares to $0.70 a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback